Moderna said on Thursday an initial study data showed its updated COVID-19 vaccine to be effective against the 'Eris' and 'Fornax' subvariants in humans.
Earlier on Thursday, Pfizer reported that its updated COVID-19 shot, co-developed with BioNTech,Eris, the nickname for EG.5, is similar to the XBB.1.5 subvariant and a sub-lineage of the still-dominant Omicron variant.
EG.5 accounted for about more than 17% of COVID-19 cases in the U.S., according to the latest government data. Infections from Fornax, officially known as FL 1.5.1, are also rising across the country. COVID-19 related hospitalizations in the U.S. are up more than 40% on low numbers from June, but are still more than 90% below peak levels hit during the Omicron outbreak in January 2022.EG.5 as a "variant of interest", indicating that it should be more closely watched than others because of mutations that might make it more contagious or severe.
Österreich Neuesten Nachrichten, Österreich Schlagzeilen
Similar News:Sie können auch ähnliche Nachrichten wie diese lesen, die wir aus anderen Nachrichtenquellen gesammelt haben.
Moderna says updated COVID vaccine effective against widely circulating Eris variantModerna Inc. said Thursday that preliminary clinical trial data show that its updated COVID-19 vaccine is effective against newer variants that are starting...
Weiterlesen »
Moderna says new Covid vaccine generated protection against Eris variant in early trialModerna’s vaccine and new shots from Pfizer and Novavax are slated to roll out within weeks, pending potential approvals from the Food and Drug Administration.
Weiterlesen »
Moderna says new Covid vaccine was effective against Eris variant in early trialModerna's vaccine and new shots from Pfizer and Novavax are slated to roll out within weeks, pending potential approvals from the Food and Drug Administration.
Weiterlesen »
What to Know About New COVID Vaccines as ‘Eris’ Variant DominatesFind out if you’ll need another shot.
Weiterlesen »
Pfizer's updated COVID shot effective against 'Eris' variant in mice studyPfizer Inc said on Thursday its updated COVID-19 shot, which is being tested against emerging variants, showed neutralizing activity against the 'Eris' subvariant in a study conducted on mice.
Weiterlesen »
The New EG.5, or Eris, COVID Symptoms You Should Know AboutEG.5 is now the dominant strain of COVID in the U.S.
Weiterlesen »